Tuesday, October 25, 2016

FOCR Hill Hearing FDA IVD LDT October 13, 2016

http://www.focr.org/events/friends-cancer-research-senate-briefing-future-precision-medicine-patient-care

Friends of Cancer Research Senate Briefing: The Future of Precision Medicine & Patient Care


Senate Briefing

The Future of Precision Medicine & Patient Care:

Current Landscape in Genomic Testing

Thursday, October 13th, 2016 - 12:00pm-1:00pm

430 Dirksen Senate Office Building

Washington, DC

 

 

Panelists: 
Jonathan Leff, Chairman, Deerfield Institute
Mike Pellini, Chief Executive Officer, Foundation Medicine
Jeff Allen, President and CEO, Friends of Cancer Research
Andrea Ferris, President and Chairman, LUNGevity
John Iafrate, Associate in Pathology, Massachusetts General Hospital
Jeff Shuren, Director, Center for Devices and Radiological Health, FDA


About the issue: Recent years have seen a proliferation in genomic testing options in oncology as more and more treatments are developed to target genetic alterations only present in subsets of the overall population. 

Additionally, advances in genomic medicine are taking place within a complex regulatory environment, with oversight split between the Food and Drug Administration (FDA) and the Centers for Medicare & Medicaid Services (CMS).

In order to promote progress in genomic testing in the field of oncology, this discussion will address:
  • The current regulatory landscape for genomic tests
  • Trends in the use of genomic tests in clinical practice
  • Strategies to enhance patient safety and access to innovative, high quality tests
  • Development of new technologies to advance precision medicine

Friends, in partnership with The Deerfield Institute, recently released the results of a comprehensive medical chart audit, which elucidated the trends of genomic testing in oncology. These results were published in the September issue of Personalized Medicine in Oncology, entitled "Use of FDA-Approved and Laboratory-Developed Tests in Advanced Non-Small Cell Lung Cancer: Results of a Retrospective Market Analysis."

Jeff Allen, Friends' President and CEO, also recently testified at the Senate Health, Education, Labor, and Pensions Committee hearing titled, "Laboratory Testing in the Era of Precision Medicine." His full testimony can be read by clicking HERE.

Lunch will be provided. This is a widely attended event.





Date: 
Thursday, October 13, 2016 -
12:00pm to 1:00pm
Event Type: 
https://events.r20.constantcontact.com/register/eventReg?llr=kwe6axbab&oeidk=a07ed8t7uas416d0d86

No comments:

Post a Comment